Neuromodulation Market Research Report by Technology (Deep Brain Stimulation, Gastric Stimulation, Sacral Nerve Stimulation, Spinal Cord Stimulation, and Vagus Nerve Stimulation), by Application (Chronic Pain, Dystonia, Essential Tremor, Gastroparesis, an

Neuromodulation Market Research Report by Technology (Deep Brain Stimulation, Gastric Stimulation, Sacral Nerve Stimulation, Spinal Cord Stimulation, and Vagus Nerve Stimulation), by Application (Chronic Pain, Dystonia, Essential Tremor, Gastroparesis, and Obsessive Compulsive Disorder) - United States Forecast to 2025 - Cumulative Impact of COVID-19

The United States Neuromodulation Market is projected to grow with a significant CAGR in the forecast period. Economic development and substantial infrastructure development have constituted regional revenue generation. Further, the patterns associated with domestic production, import and export, and consumption have helped market participants to analyze and capitalize on potential opportunities. Besides, the qualitative and quantitative parameters provided in the report with detailed analysis highlights the driving and restraining factors of the United States Neuromodulation Market.

Market Segmentation & Coverage:

This research report categorizes the Neuromodulation to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Technology, the Neuromodulation Market studied across Deep Brain Stimulation, Gastric Stimulation, Sacral Nerve Stimulation, Spinal Cord Stimulation, and Vagus Nerve Stimulation.
Based on Application, the Neuromodulation Market studied across Chronic Pain, Dystonia, Essential Tremor, Gastroparesis, Obsessive Compulsive Disorder, Parkinson’s Disease, Refractory Epilepsy, Treatment Resistant Depression, and Urinary Fecal Incontinence.

Company Usability Profiles:

The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the United States Neuromodulation Market including Boston Scientific Corporation, Cochlear Ltd., Cyberonics, Medtronic Plc, and St. Jude Medical.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Neuromodulation Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on sulfuric acid offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as:

1. What is the market size and forecast of the United States Neuromodulation Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States Neuromodulation Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Neuromodulation Market?
4. What is the competitive strategic window for opportunities in the United States Neuromodulation Market?
5. What are the technology trends and regulatory frameworks in the United States Neuromodulation Market?
6. What are the modes and strategic moves considered suitable for entering the United States Neuromodulation Market?


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. Executive Summary
3.1. Market Outlook
3.2. Technology Outlook
3.3. Application Outlook
3.4. Competitor Outlook
4. Market Overview
4.1. Introduction
5. Market Dynamics
5.1. Introduction
5.2. Drivers
5.3. Restraints
5.4. Opportunities
5.5. Challenges
6. United States Neuromodulation Market, By Technology
6.1. Introduction
6.2. Deep Brain Stimulation
6.3. Gastric Stimulation
6.4. Sacral Nerve Stimulation
6.5. Spinal Cord Stimulation
6.6. Vagus Nerve Stimulation
7. United States Neuromodulation Market, By Application
7.1. Introduction
7.2. Chronic Pain
7.3. Dystonia
7.4. Essential Tremor
7.5. Gastroparesis
7.6. Obsessive Compulsive Disorder
7.7. Parkinson’s Disease
7.8. Refractory Epilepsy
7.9. Treatment Resistant Depression
7.10. Urinary Fecal Incontinence
8. 360iResearch Competitive Strategic Window
8.1. Introduction
8.2. 360iResearch Competitive Strategic Window, by Technology
8.3. 360iResearch Competitive Strategic Window, by Application
9. Competitive Landscape
9.1. 360iResearch FPNV Positioning Matrix
9.1.1. Quadrants
9.1.2. Business Strategy
9.1.3. Product Satisfaction
9.2. 360iResearch Market Ranking Analysis
9.3. 360iResearch Market Share Analysis
9.4. 360iResearch Competitive Scenario
9.4.1. Merger & Acquisition
9.4.2. Agreement, Collaboration, & Partnership
9.4.3. New Product Launch & Enhancement
9.4.4. Investment & Funding
9.4.5. Award, Recognition, & Expansion
10. Company Usability Profiles
10.1. Boston Scientific Corporation
10.2. Cochlear Ltd.
10.3. Cyberonics
10.4. Medtronic Plc
10.5. St. Jude Medical
11. Appendix
11.1. Discussion Guide
11.2. Edition Details
11.3. License Details
11.4. Pricing Details
List of Figures
FIGURE 1. UNITED STATES NEUROMODULATION MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES NEUROMODULATION MARKET: RESEARCH EXECUTION
FIGURE 3. UNITED STATES NEUROMODULATION MARKET SIZE, 2019 VS 2025 (USD MILLION)
FIGURE 4. UNITED STATES NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2019 VS 2025 (USD MILLION)
FIGURE 5. UNITED STATES NEUROMODULATION MARKET SIZE, BY APPLICATION, 2019 VS 2025 (USD MILLION)
FIGURE 6. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES NEUROMODULATION MARKET, BY TYPE
FIGURE 7. UNITED STATES NEUROMODULATION MARKET SIZE, 2017-2025 (USD MILLION)
FIGURE 8. UNITED STATES NEUROMODULATION MARKET: MARKET DYNAMICS
FIGURE 9. UNITED STATES NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2019 VS 2025 (USD MILLION)
FIGURE 10. UNITED STATES NEUROMODULATION MARKET SIZE, BY APPLICATION, 2019 VS 2025 (USD MILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2025 (USD MILLION)
FIGURE 12. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES NEUROMODULATION MARKET SIZE, BY APPLICATION, 2025 (USD MILLION)
FIGURE 13. UNITED STATES NEUROMODULATION MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 14. UNITED STATES NEUROMODULATION MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
List of Tables
TABLE 1. UNITED STATES NEUROMODULATION MARKET SIZE, 2017-2025 (USD MILLION)
TABLE 2. UNITED STATES NEUROMODULATION MARKET SIZE, BY DEEP BRAIN STIMULATION, 2017-2025 (USD MILLION)
TABLE 3. UNITED STATES NEUROMODULATION MARKET SIZE, BY GASTRIC STIMULATION, 2017-2025 (USD MILLION)
TABLE 4. UNITED STATES NEUROMODULATION MARKET SIZE, BY SACRAL NERVE STIMULATION, 2017-2025 (USD MILLION)
TABLE 5. UNITED STATES NEUROMODULATION MARKET SIZE, BY SPINAL CORD STIMULATION, 2017-2025 (USD MILLION)
TABLE 6. UNITED STATES NEUROMODULATION MARKET SIZE, BY VAGUS NERVE STIMULATION, 2017-2025 (USD MILLION)
TABLE 7. UNITED STATES NEUROMODULATION MARKET SIZE, BY CHRONIC PAIN, 2017-2025 (USD MILLION)
TABLE 8. UNITED STATES NEUROMODULATION MARKET SIZE, BY DYSTONIA, 2017-2025 (USD MILLION)
TABLE 9. UNITED STATES NEUROMODULATION MARKET SIZE, BY ESSENTIAL TREMOR, 2017-2025 (USD MILLION)
TABLE 10. UNITED STATES NEUROMODULATION MARKET SIZE, BY GASTROPARESIS, 2017-2025 (USD MILLION)
TABLE 11. UNITED STATES NEUROMODULATION MARKET SIZE, BY OBSESSIVE COMPULSIVE DISORDER, 2017-2025 (USD MILLION)
TABLE 12. UNITED STATES NEUROMODULATION MARKET SIZE, BY PARKINSON’S DISEASE, 2017-2025 (USD MILLION)
TABLE 13. UNITED STATES NEUROMODULATION MARKET SIZE, BY REFRACTORY EPILEPSY, 2017-2025 (USD MILLION)
TABLE 14. UNITED STATES NEUROMODULATION MARKET SIZE, BY TREATMENT RESISTANT DEPRESSION, 2017-2025 (USD MILLION)
TABLE 15. UNITED STATES NEUROMODULATION MARKET SIZE, BY URINARY FECAL INCONTINENCE, 2017-2025 (USD MILLION)
TABLE 16. UNITED STATES NEUROMODULATION MARKET: SCORES
TABLE 17. UNITED STATES NEUROMODULATION MARKET: BUSINESS STRATEGY
TABLE 18. UNITED STATES NEUROMODULATION MARKET: PRODUCT SATISFACTION
TABLE 19. UNITED STATES NEUROMODULATION MARKET: RANKING
TABLE 20. UNITED STATES NEUROMODULATION MARKET: MERGER & ACQUISITION
TABLE 21. UNITED STATES NEUROMODULATION MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 22. UNITED STATES NEUROMODULATION MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 23. UNITED STATES NEUROMODULATION MARKET: INVESTMENT & FUNDING
TABLE 24. UNITED STATES NEUROMODULATION MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 25. UNITED STATES NEUROMODULATION MARKET: EDITION DETAILS
TABLE 26. UNITED STATES NEUROMODULATION MARKET: LICENSE DETAILS
TABLE 27. UNITED STATES NEUROMODULATION MARKET: PRICING DETAILS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook